RedHill Biopharma (RDHL) to Present Positive Results of the First Phase III study with RHB-105 at Innovations in Gastroenterology 2017 Symposium
Tweet Send to a Friend
RedHill Biopharma Ltd. (NASDAQ: RDHL) announced that Ira Kalfus, MD, Medical Director at RedHill, will present the positive final results ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
